Back to Trades
Total Value
$354.4K
Filing Date
Jul 20, 2026
1 transactions
Trade Summary
On Jul 16, 2026, Silva Raul R., EVP and CSO, reported $354.4K of Cingulate Inc. (CING) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $4.43. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Cingulate Inc.
- Ticker Symbol
- CING
- CIK
- 0001862150
Insider Information
- Name
- Silva Raul R.
- Role
- EVP and CSO
- Location
- KANSAS CITY, KS
Filing Details
- Filing Date
- Jul 20, 2026
- Transaction Date
- Jul 16, 2026
- Accession Number
- 0001493152-26-033959
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 16, 2026 | CING derivative | 53,600 | $4.43 | Grant/Award | $237.4K |
| Jul 16, 2026 | CING derivative | 26,400 | $4.43 | Grant/Award | $117.0K |
Want live alerts when Silva Raul R. trades again?
Download Insider Trades to track CING, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.
- (F2)Vested option only becomes exercisable if the Issuer's NDA for CTx-1301 is approved by the FDA during 2027.
- (F3)If the Issuer's NDA for CTx-1301 is not approved by the FDA during 2027, the option, including any vested portion, shall terminate.